Τίτλος:
Long-term safety of deferiprone treatment in children from the mediterranean region with beta-thalassemia major: The DEEP-3 multi-center observational safety study
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Συγγραφείς:
Botzenhardt, S.
Felisi, M.
Bonifazi, D.
Del Vecchio, G.C.
Putti, M.C.
Kattamis, A.
Ceci, A.
Wong, I.C.K.
Neubert, A.
DEEP consortium (collaborative group)
Περιοδικό:
Haematologica-the hematology journal
Εκδότης:
Ferrata Storti Foundation
Λέξεις-κλειδιά:
alanine aminotransferase; deferiprone; deferiprone; iron chelating agent, abdominal pain; agranulocytosis; alanine aminotransferase level; Albania; aminotransferase blood level; arthralgia; arthropathy; beta thalassemia; blood transfusion; body weight gain; chelation therapy; child; cohort analysis; Cyprus; diarrhea; drug safety; drug withdrawal; dyspepsia; Egypt; endocrine disease; fatigue; female; follow up; Greece; hearing impairment; heart disease; hospitalization; human; hypersalivation; incidence; iron chelation; Italy; joint swelling; kidney dysfunction; knee; Letter; leukopenia; long term care; major clinical study; male; monotherapy; multicenter study; nausea and vomiting; neurologic disease; neutropenia; observational study; preschool child; school child; skin manifestation; Southern Europe; splenectomy; splenomegaly; thrombocytopenia; Tunisia; age; beta thalassemia; clinical trial; complication; iron overload; Southern Europe; treatment outcome, Age Factors; beta-Thalassemia; Child; Deferiprone; Humans; Iron Chelating Agents; Iron Overload; Mediterranean Region; Treatment Outcome
DOI:
10.3324/haematol.2017.176065
